NEW YORK, April 24 – Qiagen has acquired Sawady, a Japanese maker of nucleic acids, in return for $18 million of Qiagen common stock, the companies said Tuesday.

The Sawady group of Tokyo, comprises three companies, Sawady Technology, Omgen, and a majority in Accord company, but operates as a single organization employing 40 people. 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The partially reinstated US travel ban leaves space for uncertainty for researchers, Nature News says.

Researchers find a number of traits differ by sex and could affect mouse model studies, according to Reuters.

Tweaking the skin microbiome could help address some skin conditions, the New York Times reports.

In PNAS this week: DNA methylation profiles of tumor tissue, gene dynamics in prokaryotes, and more.